LMG Life Sciences Awards EMEA 2022: information and updates

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

LMG Life Sciences Awards EMEA 2022: information and updates

lmg-life-sciences-awards-for-dat-600x400-emea.png

Important information and updates for the LMG Life Sciences Awards 2022

We are excited to inform you that the preeminent industry recognition programme for legal work in the life sciences industry, LMG Life Sciences Awards, is returning for 2022.


As you may have seen, we have updated the title of the awards to be inclusive of firms not only in Europe but also throughout the Middle East and Africa. 



In our research cycle we will ask that you submit nominations for leading practitioners, firms, cases, and deals. 



We will be recognising the top work completed by private practice firms, as well as in-house counsel, from 2021. 



Register your interest today so you do not miss out! 


more from across site and SHARED ros bottom lb

More from across our site

Amita Haylock discusses building an integrated Asia practice as clients increasingly demand that firms combine IP, technology and data expertise
François Pochart, Grégoire Desrousseaux and Lionel Martin, long-standing figures in the firm’s patent litigation team, are set to help launch a Paris-based litigation offering
The Unitary Patent has passed 100,000 registrations, but new data raises the question of whether 30% uptake is a ceiling or a staging post for further growth, say Michael Nielsen and Darren Smyth of EIP and Andrew Samm at Patently
The new generation of in-house IP leaders want commercial judgment, accessibility and flexibility, with AI raising expectations around both fees and delivery
The firm launched a San Diego office earlier this month, but California investment and expansion is far from complete
The industry’s response to AI requires an unfamiliar ingredient as firms battle to shape their futures
The firm is looking beyond replacing recently departed talent, betting instead on senior leaders to strengthen and expand its patent litigation platform
Olga Partington, director in Sterne Kessler’s biotechnology and chemical practice group, shares why a patent's vulnerability peaks when it is young, rather than when it is most valuable, under the PTAB's new framework
IP experts gathered in San Francisco last week to discuss the changing global SEP landscape and new licensing models for AI infrastructure
SKW Schwarz partner Daniel Kendziur explains how new green claims rules are changing his workload and bringing him into direct contact with marketing, PR and government affairs teams
Gift this article